{
  "description": "sample Github_medium/o47111.json",
  "meta": {
    "full_size": 2170,
    "stripped_size": 2170,
    "features": [
      "additionalItems",
      "additionalProperties",
      "items"
    ],
    "raw_features": [
      "$schema",
      "_boolSchema",
      "id",
      "properties",
      "type",
      "type:array",
      "type:object",
      "type:string"
    ]
  },
  "schema": {
    "$schema": "http://json-schema.org/draft-04/schema#",
    "id": "https://dcc.icgc.org/drug-text",
    "type": "object",
    "properties": {
      "atc_codes_code": {
        "id": "https://dcc.icgc.org/drug-text/atc_codes_code",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/atc_codes_code/0",
          "type": "string"
        },
        "additionalItems": false
      },
      "atc_codes_description": {
        "id": "https://dcc.icgc.org/drug-text/atc_codes_description",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/atc_codes_description/0",
          "type": "string"
        },
        "additionalItems": false
      },
      "atc_level5_codes": {
        "id": "https://dcc.icgc.org/drug-text/atc_level5_codes",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/atc_level5_codes/0",
          "type": "string"
        },
        "additionalItems": false
      },
      "drug_class": {
        "id": "https://dcc.icgc.org/drug-text/drug_class",
        "type": "string"
      },
      "external_references_chembl": {
        "id": "https://dcc.icgc.org/drug-text/external_references_chembl",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/external_references_chembl/0",
          "type": "string"
        },
        "additionalItems": false
      },
      "external_references_drugbank": {
        "id": "https://dcc.icgc.org/drug-text/external_references_drugbank",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/external_references_drugbank/0",
          "type": "string"
        },
        "additionalItems": false
      },
      "id": {
        "id": "https://dcc.icgc.org/drug-text/id",
        "type": "string"
      },
      "inchikey": {
        "id": "https://dcc.icgc.org/drug-text/inchikey",
        "type": "string"
      },
      "name": {
        "id": "https://dcc.icgc.org/drug-text/name",
        "type": "string"
      },
      "synonyms": {
        "id": "https://dcc.icgc.org/drug-text/synonyms",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/synonyms/1",
          "type": "string"
        },
        "additionalItems": false
      },
      "trials_conditions_name": {
        "id": "https://dcc.icgc.org/drug-text/trials_conditions_name",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/trials_conditions_name/185",
          "type": "string"
        },
        "additionalItems": false
      },
      "trials_description": {
        "id": "https://dcc.icgc.org/drug-text/trials_description",
        "type": "array",
        "items": {
          "id": "https://dcc.icgc.org/drug-text/trials_description/155",
          "type": "string"
        },
        "additionalItems": false
      },
      "type": {
        "id": "https://dcc.icgc.org/drug-text/type",
        "type": "string"
      }
    },
    "additionalProperties": false
  },
  "tests": [
    {
      "description": "llama 70b generated positive",
      "valid": true,
      "data": {
        "atc_codes_code": [
          "L01BC01",
          "L01BC02"
        ],
        "atc_codes_description": [
          "Gemcitabine",
          "Gemcitabine hydrochloride"
        ],
        "atc_level5_codes": [
          "Gemcitabine",
          "Gemcitabine hydrochloride"
        ],
        "drug_class": "Antineoplastic",
        "external_references_chembl": [
          "CHEMBL1201121",
          "CHEMBL1201122"
        ],
        "external_references_drugbank": [
          "DB00441",
          "DBSALT000001"
        ],
        "id": "DRUG-000001",
        "inchikey": "SXASXUJHJHJHJHJHJHJHJHJ",
        "name": "Gemcitabine",
        "synonyms": [
          "Gemzar",
          "Gemcitabine hydrochloride"
        ],
        "trials_conditions_name": [
          "Breast Cancer",
          "Lung Cancer"
        ],
        "trials_description": [
          "A Phase III Randomized Trial of Gemcitabine and Paclitaxel versus Paclitaxel Alone in Patients with Metastatic Breast Cancer",
          "A Phase II Randomized Trial of Gemcitabine and Cisplatin versus Cisplatin Alone in Patients with Advanced Non-Small Cell Lung Cancer"
        ],
        "type": "Small Molecule"
      }
    },
    {
      "description": "llama 70b generated positive",
      "valid": true,
      "data": {
        "atc_codes_code": [
          "L01BC01",
          "L01BC02"
        ],
        "atc_codes_description": [
          "Monoclonal antibodies",
          "Interferons"
        ],
        "atc_level5_codes": [
          "rituximab",
          "interferon alfa-2a"
        ],
        "drug_class": "Monoclonal antibody",
        "external_references_chembl": [
          "CHEMBL1201571",
          "CHEMBL1201572"
        ],
        "external_references_drugbank": [
          "DB00073",
          "DB00074"
        ],
        "id": "DRUG_123",
        "inchikey": "InChIKey=ABCDEF",
        "name": "Rituximab",
        "synonyms": [
          "MabThera",
          "Rituxan"
        ],
        "trials_conditions_name": [
          "Follicular lymphoma",
          "Diffuse large B-cell lymphoma"
        ],
        "trials_description": [
          "A phase III study of rituximab in combination with chemotherapy for the treatment of follicular lymphoma",
          "A phase II study of rituximab in combination with chemotherapy for the treatment of diffuse large B-cell lymphoma"
        ],
        "type": "Biological"
      }
    },
    {
      "description": "llama-70b generated negative; focus on additionalItems keyword",
      "valid": false,
      "rust_error": "{\"id\":\"https://dcc.icgc.org/drug-text/atc_codes_code/2\",\"type\":\"string\"} is not of type \"string\"",
      "python_error": "{'id': 'https://dcc.icgc.org/drug-text/atc_codes_code/2', 'type': 'string'} is not of type 'string'\n\nFailed validating 'type' in schema['properties']['atc_codes_code']['items']:\n    {'id': 'https://dcc.icgc.org/drug-text/atc_codes_code/0',\n     'type': 'string'}\n\nOn instance['atc_codes_code'][2]:\n    {'id': 'https://dcc.icgc.org/drug-text/atc_codes_code/2',\n     'type': 'string'}",
      "data": {
        "atc_codes_code": [
          "L01BC01",
          "L01BC02",
          {
            "id": "https://dcc.icgc.org/drug-text/atc_codes_code/2",
            "type": "string"
          }
        ],
        "atc_codes_description": [
          "Monoclonal antibodies",
          "Interferons"
        ],
        "atc_level5_codes": [
          "rituximab",
          "interferon alfa-2a"
        ],
        "drug_class": "Monoclonal antibody",
        "external_references_chembl": [
          "CHEMBL1201571",
          "CHEMBL1201572"
        ],
        "external_references_drugbank": [
          "DB00073",
          "DB00074"
        ],
        "id": "DRUG_123",
        "inchikey": "InChIKey=ABCDEF",
        "name": "Rituximab",
        "synonyms": [
          "MabThera",
          "Rituxan"
        ],
        "trials_conditions_name": [
          "Follicular lymphoma",
          "Diffuse large B-cell lymphoma"
        ],
        "trials_description": [
          "A phase III study of rituximab in combination with chemotherapy for the treatment of follicular lymphoma",
          "A phase II study of rituximab in combination with chemotherapy for the treatment of diffuse large B-cell lymphoma"
        ],
        "type": "Biological"
      }
    },
    {
      "description": "llama-70b generated negative",
      "valid": false,
      "rust_error": "12345 is not of type \"string\"",
      "python_error": "Additional properties are not allowed ('foo' was unexpected)\n\nFailed validating 'additionalProperties' in schema:\n    {'$schema': 'http://json-schema.org/draft-04/schema#',\n     'id': 'https://dcc.icgc.org/drug-text',\n     'type': 'object',\n     'properties': {'atc_codes_code': {'id': 'https://dcc.icgc.org/drug-text/atc_codes_code',\n                                       'type': 'array',\n                                       'items': {'id': 'https://dcc.icgc.org/drug-text/atc_codes_code/0',\n                                                 'type': 'string'},\n                                       'additionalItems': False},\n                    'atc_codes_description': {'id': 'https://dcc.icgc.org/drug-text/atc_codes_description',\n                                              'type': 'array',\n                                              'items': {'id': 'https://dcc.icgc.org/drug-text/atc_codes_description/0',\n                                                        'type': 'string'},\n                           .. (4377 more)",
      "data": {
        "atc_codes_code": [
          "L01BC01",
          12345
        ],
        "atc_codes_description": [
          "Monoclonal antibodies",
          "Interferons"
        ],
        "atc_level5_codes": [
          "rituximab",
          "interferon alfa-2a"
        ],
        "drug_class": "Monoclonal antibody",
        "external_references_chembl": [
          "CHEMBL1201571",
          "CHEMBL1201572"
        ],
        "external_references_drugbank": [
          "DB00073",
          "DB00074"
        ],
        "id": "DRUG_123",
        "inchikey": "InChIKey=ABCDEF",
        "name": "Rituximab",
        "synonyms": [
          "MabThera",
          "Rituxan",
          "extraValue"
        ],
        "trials_conditions_name": [
          "Follicular lymphoma",
          "Diffuse large B-cell lymphoma"
        ],
        "trials_description": [
          "A phase III study of rituximab in combination with chemotherapy for the treatment of follicular lymphoma",
          "A phase II study of rituximab in combination with chemotherapy for the treatment of diffuse large B-cell lymphoma"
        ],
        "type": "Biological",
        "foo": "bar"
      }
    }
  ]
}